|
|
|
Operational and financial highlights
Operational Highlights
- Strong performance of South Africa’s business
- Successful unwinding of Netpartner cross shareholding
- Medicross acquisition of Prime Cure
- R1 billion value created for Health Partners for Life BEE shareholders
- Acquisition of a controlling 52,6% interest in GHG in the UK
|
SA patient days |
SA length of stay (days) |
SA EBITDA1 margin (R billion) |
|
|
|
|
1 Before BEE share-based expense
Financial Highlights
- 54% increase in Group revenue to R11,6 billion
- 11% growth in South African revenue to R8,2 billion
- 30% growth in Group operating profit to R1,6 billion
- 20,5% SA EBITDA1 margin, up from 19,6%
- 20% growth in South African stand-alone adjusted2 HEPS to 70,5 cents per share
Group revenue
(R million) |
Adjusted1 HEPS
(cents) |
Capital distribution per share
(cents)
|
|
|
|
 |
1 Before BEE share-based expense
2 Adjusted to exclude BEE share-based expense and GHG effects
|
